Results 141 to 150 of about 5,120 (192)

Principles and Current Clinical Landscape of Multispecific Antibodies against Cancer

open access: yesInternational Journal of Molecular Sciences, 2021
Building upon the resounding therapeutic success of monoclonal antibodies, and supported by accelerating progress in engineering methods, the field of multispecific therapeutic antibodies is growing rapidly.
Petros Christopoulos, Hannah Schindler
exaly   +2 more sources

Identification of multispecific organic anion transporter 2 expressed predominantly in the liver [PDF]

open access: yesFEBS Letters, 1998
In the present study, we demonstrate that NLT (novel liver-specific transport protein) is a multispecific organic anion transporter of the liver.
Yoshikatsu Kanai   +2 more
exaly   +2 more sources

Molecular imaging supports the development of multispecific cancer antibodies [PDF]

open access: yesNature Reviews Clinical Oncology
Multispecific antibodies are engineered antibody derivatives that can bind to two or more distinct epitopes or antigens. Unlike mixtures of monospecific antibodies, the binding properties of multispecific antibodies enable two specific molecules to be ...
Marjolijn N Lub-de Hooge   +1 more
exaly   +2 more sources

Multispecific monoclonal antibodies

Immunology Today, 1986
Monoclonal antibodies are frequently shown to participate in unexpected cross reactions involving two apparently dissimilar antigens. This can be attributed either to partial epitope identity or to irrelevant interactions involving additional binding capacity of the antibody.
D, Isenberg, C, Dudeney, W, Williams
openaire   +4 more sources

Molecular mechanism of multispecific recognition of Calmodulin through conformational changes

open access: yesProceedings of the National Academy of Sciences of the United States of America, 2017
Significance Understanding how Calmodulin (CaM) is able to recruit more than 300 binding targets is crucial for solving the multispecificity in molecular recognition.
Jin Wang, Fei Liu, Peter Lu
exaly   +2 more sources

Multispecific myeloid defensins

Current Opinion in Hematology, 2007
This review describes recent progress in our understanding of defensins and their contributions to innate immunity. Defensins are small, cysteine-rich endogenous antibiotic peptides. Human neutrophils contain large amounts of three alpha-defensins (HNP-1-HNP-3), and smaller amounts of a fourth, HNP-4. Monocytes and macrophages generally lack defensins,
openaire   +2 more sources

Expression of Multispecific Antibodies

Bi- and multispecific antibody formats allow the development of new therapeutic strategies to address previously unmet medical needs. However, due to the increased complexity (e.g., the interface design and the presence of multiple binders), such molecules are generally more challenging to express and purify compared to standard monoclonal antibodies ...
Megane, Peltret   +5 more
openaire   +2 more sources

Multispecificity of Monoclonal Rheumatoid Factor

International Archives of Allergy and Applied Immunology, 2009
The study involved a monoclonal rheumatoid factor referred to as RF-AN, obtained by Steinitz and his associates from IgG-reactive human lymphocytes ‘immortalized’ by infection with Epstein-Barr virus. RF-AN combined with red blood cells (RBC) sensitized by either human or rabbit IgG antibodies.
F, Milgrom, Z, Swierczynska
openaire   +2 more sources

Evidence for multispecificity of antibody molecules

Nature, 1977
ONE of the salient questions in immunology concerns the means by which the immune system is capable of recognising an apparently limitless variety of antigenic determinants, including many that presumably did not exist during its evolution. Three major hypotheses have been put forward to explain the diversity of the immune response: a stringent germ ...
D J, Cameron, B F, Erlanger
openaire   +2 more sources

Home - About - Disclaimer - Privacy